February 29, 2012
Illumina Inc.'s DNA sequencing products infringe a LadaTech LLC patent related to genome analysis technology, a Delaware federal jury ruled Tuesday, rejecting Illumina's claims that the patent is invalid due to anticipation or obviousness.